The move offers new hope to thousands of people in the early stages of Alzheimer's who have been denied the drugs.
Neil Hunt, Chief Executive of Alzheimer's Society, described the decision as a ‘small victory' in the battle to see justice for people with Alzheimer's and their families.
‘Having access to NICE's model will allow us to scrutinise NICE's calculation and to try and make sense of this unfathomable decision.
‘We strongly believe that NICE's decision to deny people in the early stages of Alzheimer's disease access to drugs is fundamentally flawed.
‘For the price of a cup of coffee, drug treatments can give people hope, dignity and time when it is the most precious.'
Comment below and tell us what you think
